Baudax Bio, Inc. (BXRXQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 25, 2024, 8:30 AM EST

Baudax Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2022 FY 2021 FY 2020 FY 2019 FY 2018 2017
Period Ending
Oct '24 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 2017
Market Capitalization
02192665-
Upgrade
Market Cap Growth
-30.95%-90.48%-30.04%-59.05%--
Upgrade
Enterprise Value
17531266-
Upgrade
Last Close Price
0.003.18306.881414.009688.01-
Upgrade
PS Ratio
0.001.3917.1753.75--
Upgrade
PB Ratio
-2.84-0.071.40-1.79-3.87-
Upgrade
EV/Sales Ratio
13.223.812.7123.35--
Upgrade
Debt / Equity Ratio
-6.76-0.330.65-0.62-0.05-
Upgrade
Asset Turnover
0.070.040.020.01--
Upgrade
Inventory Turnover
-2.800.61---
Upgrade
Quick Ratio
0.020.261.051.682.30-
Upgrade
Current Ratio
0.070.301.502.032.610.11
Upgrade
Return on Assets (ROA)
-114.93%-70.57%-53.66%-56.74%-55.85%-119.93%
Upgrade
Return on Capital (ROIC)
--819.79%-406.39%---
Upgrade
Earnings Yield
-19085320.00%-3332.06%-106.63%-287.17%-50.32%-
Upgrade
FCF Yield
-2734829.85%-1576.23%-266.85%-168.67%-79.38%-
Upgrade
Buyback Yield / Dilution
-2403.74%-505.82%-311.07%---
Upgrade
Total Shareholder Return
-2403.74%-505.82%-311.07%---
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.